Business

BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines

Financial Post · August 31, 2026 at 3:04 p.m.

SAN CARLOS, Calif. -- BeOne Medicines , Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S.

Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale.

The agreement builds on BeOne's longstanding commitment to patient access and investment in research and scientific innovation.

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines

More from Financial Post

Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans

Teva and Trump Administration Announce Intent to Reach Agreement around Affordable Medicines and Supply Chain Security for Patients in the U.S.

NanoXplore to Host a Webcast to Discuss Fourth Quarter Results on September 15th, 2026

Definium Therapeutics Announces New Employee Inducement Grants

More in Business

Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans

Teva and Trump Administration Announce Intent to Reach Agreement around Affordable Medicines and Supply Chain Security for Patients in the U.S.

NanoXplore to Host a Webcast to Discuss Fourth Quarter Results on September 15th, 2026

Definium Therapeutics Announces New Employee Inducement Grants

Summer is ending, emergencies aren’t: The Canadian Red Cross urges Canadians to prepare

PenderFund Capital Management launches Global Small/Mid Cap Opportunities Fund